REFERENCES
- Snyder S. R., Welty E. V., Walder R. Y., Williams L. A., Walder J. A. HbXL99α: A hemoglobin derivative that is cross-linked between the α subunits is useful as a blood substitute. Proc. Natl. Acad. Sci. 1987; 84: 7280–7284
- Chang T. M.S. Pharmaceutical and therapeutic applications of artificial cells including microencapsulation. European Journal of Pharmaceutics and Biopharmaceutics 1998; 45: 3–8
- Chang T. M.S. Artificial Cells. Charles C. Thomas, Springfield, IL 1972; 4
- Chang T. M.S. Attempts to find a method to prepare artificial hemoglobin corpuscles. Biomaterials, Artificial Cells and Artificial Organs 1988; 16(1–3)1–19
- Davis T. A., Asher W. J., Wallace H. W. Artificial red cells with crosslinked hemoglobin membranes. Applied Biochemistry and Biotechnology 1984; 10: 123–132
- Eisman J. M., Schnaare R. L. The formation of a crosslinked carboxyhemoglobin membrane at an organic-aqueous interface. Art. Cells, Blood Subs., and Immob. Biotech. 1996; 24(3)185–196
- Keller K. H., Canales E. R., Yum S., II. Tracer and mutual diffusion coefficients of proteins. The Journal of Physical Chemistry 1971; 75(3)379–387
- Levy M. C., Rambourg P., Levy J., Potron G. Microencapsulation IV: Cross-linked hemoglobin microcapsules. Journal of Pharmaceutical Sciences 1982; 71(7)759–762